BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3092732)

  • 1. Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.
    Manian FA; Alford RH
    Antimicrob Agents Chemother; 1986 Jul; 30(1):35-8. PubMed ID: 3092732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH; Spohr M
    Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
    Sanders CC; Iaconis JP; Bodey GP; Samonis G
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1365-9. PubMed ID: 3143303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.
    Tausk F; Stratton CW
    Antimicrob Agents Chemother; 1986 Oct; 30(4):584-9. PubMed ID: 3098162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
    Rittenhouse SF; Miller LA; Utrup LJ; Poupard JA
    Diagn Microbiol Infect Dis; 1996 Sep; 26(1):1-6. PubMed ID: 8950521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C; Kitzis M; Le Mée J
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.
    Fuchs PC; Jones RN; Barry AL
    J Clin Microbiol; 1989 Nov; 27(11):2475-81. PubMed ID: 2808671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D; Le Noc P; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
    Chattopadhyay B; Hall I
    Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Fass RJ; Prior RB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
    Barry AL
    Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations.
    Fuchs PC; Barry AL; Baker CN; Murray PR; Washington JA
    J Clin Microbiol; 1992 Aug; 30(8):2191-4. PubMed ID: 1500533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.